![David Giljohann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Giljohann
Director Ejecutivo en
EVOQ Therapeutics, Inc.
.
Perfil
David A. Giljohann is Chief Executive Officer at EVOQ Therapeutics, Inc. since 2023.
Former roles include Founding Scientist at Aurasense LLC, Chief Operating Officer & Principal Scientist at Exicure Operating Co. from 2012 to 2013, and Chief Technology Officer at Exicure, Inc. from 2021 to 2022.
Education includes undergraduate and doctorate degrees from Northwestern University.
Cargos activos de David Giljohann
| Empresas | Cargo | Inicio |
|---|---|---|
EVOQ Therapeutics, Inc.
 EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Director Ejecutivo | 01/01/2023 |
Antiguos cargos conocidos de David Giljohann.
| Empresas | Cargo | Fin |
|---|---|---|
| EXICURE, INC. | Director Ejecutivo | 10/12/2021 |
Aurasense LLC
 Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Director Técnico/Científico/I+D | 01/01/2009 |
Exicure Operating Co.
 Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Director Ejecutivo | - |
Formación de David Giljohann.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
29
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Aurasense LLC
Aurasense LLC BiotechnologyHealth Technology Engages in advanced nanotechnology solutions | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exicure Operating Co.
Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Develops immunomodulatory and gene regulating drugs | Health Technology |
Exicure, Inc.
 Exicure, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops nucleic acid therapies against to neurological disorders and hair loss | Health Technology |
EVOQ Therapeutics, Inc.
EVOQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in developing new vaccine strategies for improving outcomes for cancer patients | Health Technology |
- Bolsa de valores
- Insiders
- David Giljohann
